MDNews - Lower Hudson/Bronx

July 2014

Issue link: https://viewer.e-digitaledition.com/i/337400

Contents of this Issue

Navigation

Page 13 of 23

At the Heart of Cancer SPECIAL CLINICAL SECTION: CARDIOLOGY MORE THAN 325,000 PEOPLE LIVING IN THE UNITED STATES HAVE SURVIVED CHILDHOOD CANCER, BUT TREATMENTS CRITICAL TO ACHIEVING REMISSION PLACE THESE PATIENTS INTO ANOTHER HIGH-RISK GROUP, WHERE LATENT EFFECTS CAN LEAD TO FATAL OUTCOMES DECADES AFTER THEIR CANCER HAS BEEN DEFEATED. By Michael Ferguson T HE FIRST GENERATIONS of childhood cancer patients who benefited from significant treatment advances in recent decades are reaching their 30s, but the threat of treatment-related cardiotoxicity is only beginning to be fully realized. The American Heart Association (AHA) has taken the first step to develop clinical guidelines that maintain the current curative trajectory of childhood cancers and assuage the possibility of cardiac disease later in life. Steven E. Lipshultz, MD, FAHA, George E. Batchelor Professor of Pediatrics and Director of the Batchelor Children's Research Institute at the University of Mia mi Miller School 1 4 | Lower Hudson/Bronx MD NEWS ■ M D N E W S . CO M

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - July 2014